Study of GW685698X In Patients With Seasonal Allergic Rhinitis

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE3

Total Enrollment

38 participants

Study Classification

INTERVENTIONAL

Study Start Date

2005-02-19

Study Completion Date

2005-04-13

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study was designed to compare the efficacy and safety of an investigational nasal spray compared with placebo nasal spray and commonly used drug in the treatment of seasonal allergic rhinitis. Allergic rhinitis is an inflammatory disorder of the upper airway that occurs following allergen exposure. The focus of this study, seasonal allergic rhinitis (SAR), is one type of allergic rhinitis that is triggered by the pollen from trees, grasses, and weeds. Typical symptoms are sneezing, nasal congestion and pruritus, rhinorrhea, and pruritic, watery, red eyes.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Once-Daily Investigational Nasal Spray In Adults And Adolescents With Seasonal Allergic Rhinitis (SAR)

NCT00197262

Rhinitis, Allergic, Seasonal

COMPLETED PHASE3

Study In Adolescent And Adult Subjects 12 Years Of Age And Older With Seasonal Allergic Rhinitis To Assess Onset of Action

NCT00118729

Rhinitis, Allergic, Seasonal

COMPLETED PHASE3

Study In Adults And Adolescents With Seasonal Allergic Rhinitis

NCT00115622

Hayfever Rhinitis, Allergic, Seasonal Seasonal Allergic Rhinitis

COMPLETED PHASE3

Seasonal Allergic Rhinitis In Pediatric Subjects

NCT00107757

Rhinitis, Allergic, Perennial

COMPLETED PHASE3

Study In Adults And Adolescents With Seasonal Allergic Rhinitis.

NCT00225823

Rhinitis, Allergic, Seasonal

COMPLETED PHASE3

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Rhinitis, Allergic, Seasonal

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Participants Investigators

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

GW685698X Aqueous Nasal Spray

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Informed consent
* Outpatient
* Diagnosis of seasonal allergic rhinitis with symptoms
* Able to comply with study procedures

Exclusion Criteria

* Significant concomitant medical condition
* Use of corticosteroids/allergy medications
* Laboratory abnormality
* Positive pregnancy test
* Allergy to any component of investigational product

Minimum Eligible Age

16 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No